Biological half life of iodine in adults with intact thryroid function and athyreotic persons


×
Rating : Rate It:
 
Embed :   
Post a comment
    Post Comment on Twitter
Comments:  



  Notes
 
 
Slide 1 : Canadian National Calibration Reference Centre for Bioassay and In Vivo Monitoring Human Monitoring Laboratory
Slide 2 : THESTUDY Purpose Update our knowledge of thyroid metabolism. Obtain new knowledge for hyperthyroid, hypothyroid and athyroid persons. Particpants Ottawa Civic Hospital. HML. Volunteers (patients) receiving diagnostic/metastatic survey doses of 131I. Protocol Repeat counts at HML. $25 per visit.
Slide 3 : KNOWNDATA ICRP78 MODEL Rest of Body Blood Thyroid 30% 0.83 d 70% 0.35 d 100% 80 d 20% 60 d 80% 15 d
Slide 4 : BIOLOGICALHALFLIFE - or, how is it obtained? The effective half life is related to: The radiological half life (8.04 d) The biological half life The 131I retention can give the biological half life l l l e r B = + l B Ln T = ( ) 2 1 2
Slide 5 : MEASUREMENTS Measurements began in March 1997 and ended in December 1999. Thyroid counts and wholebody counts PHA / MCS
Slide 6 : THESUBJECTS 39 9 0.07 Sv 3.3 Sv Activities given: Set 1: ~333 kBq Set 2: ~150 MBq Up to six counts per subject Composed of three groups
Slide 7 : TheGROUPS Hypothyroid - uptake 0% - 6%; 3 persons. T½ = 29.3 ± 8.8 (smean) Euthyroid - uptake 6% - 22%; 27 persons. T½ = 66.1 ± 6.3 (smean) Hyperthyroid - uptake >22%; 9 persons. T½ = 38.2 ± 8.6 (smean) Athyroid - uptake ~ 0% (1 - 12%); 9 persons. T½ = 1.0 ± 0.2 (smean) T½ = 18.4 ± 1.1 (smean)
Slide 8 : UPTAKES
Slide 9 : SET2RESULTS SPECIMEN PLOT ?e = 0.113 d-1 ?B = 0.026 d-1 T1/2 = 26.15 d
Slide 10 : SET4RESULTS SPECIMEN PLOT ?e = 0.121 d-1 ?B = 0.035 d-1 T1/2 = 19.74 d ?e = 0.806 d-1 ?B = 0.72 d-1 T1/2 = 0.96 d
Slide 11 : RESULTSUMMARY Sets 1 - 3
Slide 12 : RESULTSUMMARY Sets 1 - 3
Slide 13 : MORESULTSUMMARY Set 4
Slide 14 : MORESULTSUMMARY Uptake(%) =16.1 ± 1.2 (smean) Half Life (d) Set 2 66.1 ± 6.3 Rest of Body Blood Thyroid 30% 0.83 d 70% 0.35 d 80 d 60 d 15 d
Slide 15 : MORESULTSUMMARY Half Life (d) Set 2 66.1 ± 6.3 Set 4 1.0 ± 0.2 Set 4 18.4 ± 1.1 Uptake(%) =16.1 ± 1.2 (smean) Blood 100% 0.35 d
Slide 16 : RETENTION R t e e e e Ln T Ln T Ln T Ln T ( ) . . . . ( ) . ( ) . ( ) . ( ) . = + + + - æ è ç ö ø ÷ - æ è ç ö ø ÷ - æ è ç ö ø ÷ - æ è ç ö ø ÷ 0 669 0 2 0 13 0 0008 2 0 25 2 57 3 2 1 03 2 18 5 Bend occurs at < 5 days Includes radioactive decay
Slide 17 : RETENTION Bend occurs at < 10 days R t e e e e Ln T Ln T Ln T Ln T ( ) . . . . ( ) . ( ) . ( ) . ( ) . = + + + - æ è ç ö ø ÷ - æ è ç ö ø ÷ - æ è ç ö ø ÷ - æ è ç ö ø ÷ 0 869 0 2 0 13 0 0008 2 0 25 2 57 3 2 1 03 2 18 5 Includes radioactive decay
Slide 18 : Uptake is too high in model. T-test (value = 11.36, tcrit = 1.68, P < 0.001) Half-life may need lowering. T-test (value = 1.97, tcrit = 1.68, P =0.027) There are two other pathways. Probably salivary glands and “rest of body” Always use individual specific parameters for case studies. CONCLUSIONS WHAT THIS STUDY HAS FOUND:
Slide 19 : H D T E N E

 



Related 

 
Free Powerpoint Templates
Add as Friend gary_h_kramer@hc-sc.gc.ca     5 Years ago.
1270 Views, 0 favourite
PowerPoint Slide Presentation on Kramer at al. Rad Prot Dosim. 102:129-135; 2002
More By User

Flag as inappropriate





Browse | Powerpoint Templates | Tags | Contact | About Us | Privacy | FAQ | Blog

© Slideworld